| Systemic and Topical Geroprotective Rejuvenation Assessed by START/REST Aging Clocks | Hydroxychloroquine, Chloroquine | Early phase 1 | Enrolling by invitation | Frontiers in Bioscience Research Institute and Aging | Oct 22, 2026 |
| Repurposing Mefloquine for Pancreatic Cancer Treatment | Mefloquine | Phase 1 | Not yet recruiting | University of Florida | Oct 15, 2026 |
| Exploratory Study on the Efficacy and Safety of Low-Dose Blinatumomab in the Treatment of Moderate to Severe Primary Sjögren's Syndrome | Hydroxychloroquine | Phase 2 | Not yet recruiting | Beijing Tongren Hospital | Oct 1, 2026 |
| Clinical Efficacy of Telitacicept in Sjögren's Disease With Interstitial Lung Disease | Hydroxychloroquine | — | Recruiting | Peking University People's Hospital | Sep 28, 2026 |
| Ethiopian Antimalarial Therapeutic Efficacy Study 2026 | Artemether, Chloroquine, Lumefantrine | — | Not yet recruiting | Ethiopian Public Health Institute | Sep 25, 2026 |
| Tafenoquine Drug Levels in Small Children | Chloroquine | Phase 2 | Not yet recruiting | University of Oxford | Sep 22, 2026 |
| ACT4RHD is an Open-label, Randomised, Adaptive Platform Trial to Evaluate Novel and Repurposed Clinical Interventions for Patients With Acute Rheumatic Fever and Carditis. ACT4RHD Seeks to Determine Whether These Interventions Reduce RHD Severity at 6 Months. | Hydroxychloroquine, Chloroquine | Phase 3 | Not yet recruiting | Starship Child Health, Te Toka Tumai Auckland | Sep 21, 2026 |
| Pilot Study of Hydroxychloroquine for the Treatment of AIMSS | Hydroxychloroquine, Chloroquine | Phase 2 | Recruiting | Indiana University | Sep 17, 2026 |
| Hydrochloroquinine & Decitabine With Venetoclax in AML | Hydroxychloroquine, Chloroquine | Phase 1 | Not yet recruiting | Rutgers, The State University of New Jersey | Sep 10, 2026 |
| Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Participants With Uncomplicated Plasmodium Falciparum Malaria (Cohort C2) | Artemether, Lumefantrine | Phase 2 | Recruiting | Novartis Pharmaceuticals | Sep 10, 2026 |
| CapeOx Combined With Anti-PD1 Antibody Plus Dihydroartemisinin as Neoadjuvant or Conversion Therapy for Microsatellite Stable Locally Advanced and Metastatic Colorectal Cancer | Artenimol | Phase 2 | Active, not recruiting | Shanghai Changzheng Hospital | Sep 3, 2026 |
| OPTIMAL LEAP: Optimizing Dihydroartemisinin-Piperaquine IPTsc Intervals to Advance Learning, Executive Function, Attendance, and Antimalarial Resistance Surveillance in Kenyan Schoolchildren | Piperaquine | Phase 3 | Not yet recruiting | Indiana University | Sep 1, 2026 |
| Tunlametinib in Combination With Pucotenlimab and Hydroxychloroquine in NRAS Mutant Melanoma | Hydroxychloroquine, Chloroquine | Phase 2 | Recruiting | Sun Yat-sen University | Aug 6, 2026 |
| The Effect of Nicorandil on Rheumatoid Arthritis Patients | Hydroxychloroquine, Chloroquine | Phase 2 / Phase 3 | Recruiting | Ain Shams University | Jul 28, 2026 |
| Study to Assess Safety and Clinical Responses With Coartem® Baby Dispersible Tablets in Paediatric Patients Weighing 2 to <5 kg With Uncomplicated Malaria | Artemether, Lumefantrine | Phase 4 | Not yet recruiting | Novartis Pharmaceuticals | Jul 20, 2026 |
| Dihydroartemisinin for MAFLD | Artenimol | Phase 1 / Phase 2 | Recruiting | The First Affiliated Hospital with Nanjing Medical University | Jul 1, 2026 |
| Phase II Study of Dysplasix™ Intravaginal Suppositories in Patients Patients With High-Risk HPV and Mild Cervical Cytologic Abnormalities | Quinine | Phase 2 | Recruiting | Amplexd Therapeutics, Inc. | May 7, 2026 |
| Safety and Efficacy of Imatinib in Combination With Artemether-Lumefantrine for Uncomplicated Malaria | Artemether, Lumefantrine | Phase 2 | Recruiting | Victoria Biomedical Research Institute | Apr 30, 2026 |
| A Multicentre, Randomised, Double-blind, Positive-control Clinical Trial Evaluating Dihydroartemisinin Tablets for the Treatment of Discoid Lupus Erythematosus | Artenimol | Phase 2 | Not yet recruiting | Kunming Pharmaceuticals, Inc. | Apr 30, 2026 |
| Tafenoquine Combinations for Improved Radical Cure Efficacy of Plasmodium Vivax | Artemether, Lumefantrine, Piperaquine | Not applicable | Not yet recruiting | Walter Reed Army Institute of Research (WRAIR) | Apr 16, 2026 |
| Theophylline, Versus Sumatriptan and Gabapentin in The Treatment of Post-Dural Puncture Headache | Halofantrine | Not applicable | Recruiting | Tanta University | Apr 7, 2026 |
| RSV Vaccination to Reduce Recurrent AECOPD | Halofantrine | Phase 4 | Not yet recruiting | Chinese University of Hong Kong | Apr 2, 2026 |
| A Clinical Study of Piperaquine, Pyronaridine, and Artesunate Administered in Combination in Healthy Adults | Piperaquine | Phase 1 | Not yet recruiting | University of Oxford | Mar 13, 2026 |
| Investigating the Pharmacology of Tafenoquine in Papua New Guinean Children With Uncomplicated Malaria | Artemether, Lumefantrine, Piperaquine | Phase 4 | Not yet recruiting | Curtin University | Feb 11, 2026 |
| Assessing the Feasibility of Combining Dihydroartemisinin Piperaquine and Primaquine for Malaria Mass Drug Administration in High Endemic Communities in the Eastern Region of Ghana | Piperaquine | Not applicable | Recruiting | Noguchi Memorial Institute for Medical Research | Feb 5, 2026 |
| Perennial Malaria Chemoprevention in the Malaria Vaccine Era | Amodiaquine, Piperaquine | Phase 4 | Not yet recruiting | Stanford University | Jan 7, 2026 |
| MDA and Targeted Control Against Plasmodium Carriage in the Sahel | Piperaquine | Not applicable | Active, not recruiting | Institut de Recherche pour le Developpement | Dec 15, 2025 |
| Intermittent Preventive Treatment of Malaria in School-age Children to Decrease Community Transmission | Piperaquine | Phase 4 | Recruiting | University of California, San Francisco | Nov 24, 2025 |
| Pandemic Influenza Vaccine in Organ Transplantation (PIVOT Trial) | Halofantrine | Phase 3 | Active, not recruiting | University Health Network, Toronto | Nov 21, 2025 |
| Efficacy of Dihydroartemisinin for Treating Acne Vulgaris | Artenimol | Early phase 1 | Recruiting | Shanghai Zhongshan Hospital | Jun 5, 2025 |
| OPTImizing Malaria And HIV Treatment in a Shifting Landscape in Africa | Amodiaquine, Artemether, Lumefantrine | Phase 4 | Recruiting | Yale University | May 13, 2025 |
| Safety of Antimalarials in the FIRst trimEster | Quinine, Artemether, Lumefantrine | Phase 3 | Recruiting | Liverpool School of Tropical Medicine | May 8, 2025 |
| A Study to Evaluate the Safety of Recombinant Herpes Zoster Vaccine for Healthy Individuals | Halofantrine | Phase 1 / Phase 2 | Recruiting | Shanghai Institute Of Biological Products | Apr 17, 2025 |
| Serological Testing and Treatment for Plasmodium Vivax Malaria: a Trial in Ethiopia and Madagascar | Amodiaquine | Phase 3 | Recruiting | London School of Hygiene and Tropical Medicine | Apr 11, 2025 |
| Dihydroartemisinin for the Treatment of Polycystic Ovary Syndrome | Artenimol | Phase 2 | Recruiting | Shanghai Zhongshan Hospital | Feb 24, 2025 |
| Reward-specific Changes of the Chemical Messenger Dopamine in the Brain of Healthy and Depressed People | Halofantrine | Phase 4 | Recruiting | Medical University of Vienna | Nov 5, 2024 |
| Targeted Antimalarial Drug Administration for Seasonal Migrant Populations in Amhara Region, Ethiopia | Artenimol | Phase 3 | Active, not recruiting | PATH | Jul 23, 2024 |
| Artesunate Ointment for the Treatment of Anal HSIL in HIV-negative Participants | Artenimol | Phase 2 | Recruiting | Frantz Viral Therapeutics, LLC | Jan 16, 2024 |
| Phase II Study of Artesunate Ointment for the Treatment of Vulvar High Grade Squamous Intraepithelial Lesions (Vulvar HSIL, VIN2/3) | Artenimol | Phase 2 | Recruiting | Frantz Viral Therapeutics, LLC | Oct 10, 2023 |
| A Study to Find Out if a Combination of 3 Medicines for the Treatment of Malaria Works as Well and is as Safe and Tolerable as Combinations of 2 Medicines | Amodiaquine | Phase 3 | Recruiting | University of Oxford | Jul 19, 2023 |
| FocaL Mass Drug Administration for Vivax Malaria Elimination | Mefloquine | Phase 3 | Recruiting | University of California, San Francisco | Jan 19, 2023 |
| Dental Biofilm Control During Orthodontic Treatment | Halofantrine | Phase 3 | Active, not recruiting | University of Rijeka | Sep 8, 2022 |
| Taste Physiology in Obese Volunteers Before and After Bariatric Surgery | Quinine | Not applicable | Recruiting | University Hospital, Basel, Switzerland | Sep 15, 2016 |